RESEARCH PAPER
Admission phenotype and 180-day mortality in older adults hospitalized with SARS-CoV-2 infection.
 
More details
Hide details
1
Multispecialist Municipal Hospital, J. Struś Memorial Hospital, Poznań, Poland
 
2
Department of Immunobiology, Poznan University of Medical Sciences, Poznań, Poland
 
3
Department and Clinic of Infectious Diseases, Hepatology and Acquired Immunodeficiencies, Poznan University of Medical Sciences, Poznań, Poland
 
4
Department of Palliative Medicine, Poznan University of Medical Sciences, Poznań, Poland
 
5
Department of Occupational Therapy, Poznan University of Medical Sciences, Poznań, Poland
 
6
Senior Institute, Department of Medical and Health Sciences, Vizja University, Warsaw, Poland
 
 
Submission date: 2026-03-22
 
 
Final revision date: 2026-04-22
 
 
Acceptance date: 2026-04-23
 
 
Online publication date: 2026-05-29
 
 
Publication date: 2026-05-29
 
 
Corresponding author
Michał Chojnicki   

Department of Immunobiology, Poznan University of Medical Sciences, Rokietnicka 8, 60-806, Poznań, Poland
 
 
Pol. Ann. Med. 2026;33:183-189
 
KEYWORDS
TOPICS
ABSTRACT
Introduction:
In older inpatients, SARS-CoV-2 positivity does not always indicate that COVID-19 is the cause of admission.

Aim:
To compare clinical profiles and 180-day mortality between older adults admitted for typical COVID-19 and those with incidental SARS-CoV-2 infection.

Material and methods:
This retrospective cohort study included 306 hospitalized patients aged ≥60 years with SARS-CoV-2 infection. Admission phenotype was manually adjudicated as typical COVID-19 respiratory disease or incidental SARS-CoV-2 infection. Baseline characteristics, multimorbidity, CRP, IL-6, D-dimer, SpO2, and 180-day mortality were analyzed. Mortality was assessed using Kaplan–Meier curves and multivariable logistic regression.

Results and discussion:
The cohort included 266 typical and 40 incidental admissions. Multimorbidity was common in both groups (79.2% vs 89.7%; p = 0.122). Typical admissions had lower SpO2 and higher CRP at admission (75.2 vs 34.8 mg/L; p = 0.007), whereas incidental admissions had higher D-dimer concentrations (2.2 vs 1.1 ng/mL; p = 0.016). Crude 180-day mortality was higher in the typical COVID-19 group (42.9% vs 22.5%; p=0.014). After adjustment for age and multimorbidity, incidental phenotype was independently associated with lower mortality odds (OR = 0.40; 95% CI: 0.18–0.89; p = 0.027).

Conclusions:
Typical COVID-19 and incidental SARS-CoV-2 infection are distinct geriatric admission phenotypes. Typical COVID-19 admissions are associated with higher 180-day mortality, independent of baseline multimorbidity.
REFERENCES (11)
1.
Klann JG, Strasser ZH, Hutch MR, et al. Distinguishing Admissions Specifically for COVID-19 From Incidental SARS-CoV-2 Admissions: National Retrospective Electronic Health Record Study. J Med Internet Res. 2022;24(5):37931. https://doi.org/10.2196/37931.
 
2.
Tsai J, Traub E, Aoki K, et al. Incidentally Detected SARS-CoV-2 Among Hospitalized Patients in Los Angeles County, August to October 2020. J Hosp Med. 2021;16(8):480–483. https://doi.org/10.12788/jhm.3....
 
3.
Hohl CM, Cragg A, Purssell E, et al. Comparing methods to classify admitted patients with SARS-CoV-2 as admitted for COVID-19 versus with incidental SARS-CoV-2: A cohort study. PLOS One. 2023;18(9):0291580. https://doi.org/10.1371/journa....
 
4.
McAlister FA, Hau JP, Xu V. The burden of incidental SARS-CoV-2 infections in hospitalized patients across pandemic waves in Canada. Sci Rep. 2023;13:6635. https://doi.org/10.1038/s41598....
 
5.
Moura CS, Morrison LJ, Hohl CM, et al. Administrative data ICD-10 diagnostic codes identifies most lab-confirmed SARS-CoV-2 admissions but misses many discharged from the Emergency Department. Sci Rep. 2024;14(1):6008. https://doi.org/10.1038/s41598....
 
6.
Oelsner EC, Krishnaswamy A, Rustamov R, Balte PP, Ali T, Allen NB. Classifying COVID-19 hospitalizations in epidemiology cohort studies: The C4R study. PLOS One. 2025;20(2):0316198. https://doi.org/10.1371/journa....
 
7.
Hewitt J, Carter B, Vilches-Moraga A, et al. The effect of frailty on survival in patients with COVID-19 (COPE): A multicentre, European, observational cohort study. Lancet Public Health. 2020;5(8):444-e451. https://doi.org/10.1016/S2468-....
 
8.
Pan D. Frailty and mortality in patients with COVID-19. Lancet Public Health. 2020;5(11):581. https://doi.org/10.1016/S2468-....
 
9.
van Son JE, Kahn ECP, van der Bol JM, Barten DG, Blomaard LC, van Dam C. A typical presentation of COVID-19 in older patients is associated with frailty but not with adverse outcomes. Eur Geriatr Med. 2023;14:285–293. https://doi.org/10.1007/s41999....
 
10.
Tavares J, Figueiredo D, Passos L, Sobrinho L, Souza E, Pedreira L. A typical Presentation of COVID-19 in Older Adults: A Scoping Review. Port JPublic Health. 2023;41(3):198–217. https://doi.org/10.1159/000534....
 
11.
Cieślińska A, Fiedorowicz E, Rozmus D, et al. Cross-sectional assessment of a history of SARS-CoV-2 infections using IgG. Pol Ann Med. 2023;30(2):91–95. https://doi.org/10.29089/paom/....
 
Journals System - logo
Scroll to top